Immune-Related Adverse Events of Checkpoint Inhibitors Immune-Related Adverse Events of Checkpoint Inhibitors

Monoclonal antibodies targeting CTLA-4 and PD-1 have immune-related adverse events that are quite different with regards to drug class and tumor type.Annals of Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news